Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-05-13
1998-05-12
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530314, 530328, A61K 3808, C07K 718
Patent
active
057505063
ABSTRACT:
Bradykinin antagonists, particularly Cys.sup.6 analogs, which have an extended hydrophobic side chain.
REFERENCES:
patent: 4693993 (1987-09-01), Stewart et al.
patent: 4801613 (1989-01-01), Stewart et al.
patent: 4923963 (1990-05-01), Stewart et al.
patent: 5162497 (1992-11-01), Coy et al.
patent: 5416191 (1995-05-01), Cheronis et al.
Vevek et al. "Succinyl Bis--Bradykinins: Potent Agonists with exceptional resistance to Enzymatic Degradation", J. Proc., 8th Am. Pept. Symp. pp. 381-384, 1983.
Schild, "pA, A New Scale for the Measurement of Drug Antagonism", Brit.j.Pharmacol. (1947),2, 189-206.
Arunlakshana et al, "Some Quantitative Uses of Drug Antagonists", Brit. J. Pharmacol. (1959), 14, 48.
Ronald M. Burch, "Bradykinin Antagonists--Basic and Clinical Research", Nova Pharmaceutical Corp. Baltimore, MD Marcel Dekker, Inc., pp. 52-55, 60-63, 80-83, date is not available.
Goodfellow Val S.
Kroona Heather B.
Whalley Eric T.
Wincott Francine E.
Zummach Dana A.
Cortech Inc.
Gupta Anish
Tsang Cecilia J.
LandOfFree
Bradykinin antagonists with extended hydrophobic side chains does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bradykinin antagonists with extended hydrophobic side chains, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bradykinin antagonists with extended hydrophobic side chains will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-979112